Navigation Links
PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
Date:6/23/2011

on of existing opioid drugs in physical matrices that are easily circumvented by simple extraction methods.  PF329's pharmacokinetic profile appears optimal for twice-daily dosing.  

The Phase I study was a single-center, dose-escalation and fixed-dose crossover, cohort study to determine the safety and pharmacokinetics of a single oral dose of PF329 in healthy subjects. Fifty-one healthy volunteers received oral doses of PF329 in solution ranging from 1 – 48 mg, and 12 received immediate release HM in approximately molar-equivalent doses.  The objectives of the study were to assess the safety, tolerability, and pharmacokinetics of PF329, as well as the pharmacokinetics of its pharmaceutically active moiety, HM.  The secondary objectives of the study were to identify appropriate doses of PF329 for subsequent clinical studies and to evaluate the effects of food on the pharmacokinetics of PF329.  HM exposures were independent of the fed / fasted state of the subjects.

Dr. Lynn Webster, a world leader in pain management and prescription drug abuse, explained, "PharmacoFore's Bio-MD™ system not only resists abuse via injection and inhalation, but, importantly, the most common method, which is oral abuse. As the Phase 1 study demonstrates, crushing or chewing will not affect the extended release profile of the delivery system. Further, unlike any other product on the market or in development, combining the Bio-MD™ and MPAR™ technologies will remove the incentive to abuse by consuming multiple pills, and protect against oral overdose."

According to Steven Passik, PhD, Professor of Psychiatry and Anesthesiology, Vanderbilt University Medical Center, "New and innovative abuse-deterrent technologies are greatly needed in our efforts to continue to treat pain and take reasonable and responsible steps to prevent abuse and diversion."

"We believe these data provide objective evidence of the viability o
'/>"/>

SOURCE PharmacoFore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FluoroPharma Announces $1.6M Capital Raise
2. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
3. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
4. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
5. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
6. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
7. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
8. Lupin Announces Launch of Generic Levaquin® Tablets
9. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
10. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
11. Oxford BioMedica Announces Ocular Programme Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... WARSAW, Ind. , Nov. 18, 2014  Zimmer ... that it has agreed with the European Commission (the ... of Zimmer,s proposed acquisition of Biomet by a limited ... with certain additional information. Deadline extensions ... been working closely with the regulatory authorities to facilitate ...
(Date:11/18/2014)... 2014  Cardica, Inc. (Nasdaq: CRDC ... approved management,s recommendation to shift Cardica,s primary focus ... XCHANGE® 30 surgical stapler to improving its performance ... result, Cardica has temporarily suspended the controlled commercial ... of the MicroCutter XCHANGE 30 surgical stapler from ...
(Date:11/18/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Monday, December 8, 2014 at 9:00 a.m. Eastern Time to ... th American Society of Hematology Annual Meeting and Exposition.  ... by dialing 877-443-5662 or access the webcast at www.isispharm.com ... time at the same address. ABOUT ISIS ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3
... May 26, 2011 Kensey Nash Corporation (Nasdaq: ... Global Healthcare Conference at The Grand Hyatt in New York, ... Kaufmann, Kensey Nash,s President and CEO, will deliver the Company,s ... live webcast of the Kensey Nash presentation, go to ...
... Pa., May 26, 2011 ViroPharma Incorporated (NASDAQ: ... Swell , a twenty-five minute film that allows families dealing ... share the challenges and triumphs of living with a chronic ... HAE, often times through many generations of the same family. ...
Cached Medicine Technology:ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 2ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 3
(Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
(Date:11/18/2014)... 2014 Recently, Wigsbuy has introduced its ... are offered at greatly discounted prices now, up to 85% ... of human hair products, offering many real and synthetic hair ... global customers, Wigsbuy uses high quality materials to make its ... with the trend. , “We are offering a full ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
(Date:11/18/2014)... By Dennis Thompson HealthDay ... doctor from Sierra Leone who became infected with Ebola in his ... Dr. Martin Salia had arrived Saturday at Nebraska Medical Center ... at a hospital in Sierra Leone,s capital city of Freetown. ... that have been ravaged by the Ebola outbreak that began last ...
(Date:11/17/2014)... 17, 2014 A Diet Doc ... throughout the country are turning back the clock on ... This is because the company has recently added their ... impressive collection of prescription and non-prescription diet products and ... Diet Doc’s best anti-aging human growth hormone ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:It Is The Most Wonderful Time To Buy Full Lace Wigs At Wigsbuy.com 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3
... Lower pay, fewer marriages among those who had depression, ... 17 (HealthDay News) -- Children who experience psychological disorders ... headed for a financially depressed adulthood, new research suggests. ... are less likely to get married or maximize their ...
... ... Village at ProprietorsGreen, a luxury senior rental community developed by Norwell-based ... has opened in Marshfield, Massachusetts. Despite an economic climate that ... on schedule, and opened with 40 percent of its independent living ...
... ... provider of solutions for the workers, compensation and liability markets, announced that it has ... drug requirements pertaining to Medicare Set-Asides (MSA). , ... Tampa, Florida (Vocus) May 17, 2010 -- PMSI ...
... diseases in middle age, despite an absence of family history ... blame, according to a new study conducted by researchers at ... the National Institutes of Health. The study also ... help identify those genetic abnormalities and allow detection before the ...
... the Queensland Institute of Medical Research (QIMR) and the Royal ... successfully treated it by performing an experimental stem cell transplant. ... out of hospital Katie Pulling had almost given up hope. ... the doctors say, ,We don,t know what is wrong, ,We ...
... ... for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very own Torque ... (PRWEB) ... know what to look for. A torque screwdriver comes in many different variations, including ...
Cached Medicine News:Health News:Kids' Psychological Problems Have Long-Term Effects 2Health News:Village at Proprietors Green Opens on South Shore, Introducing Innovative Senior Living to Boston Area 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 3Health News:Lung disease may be genetic, despite lack of family history 2Health News:Australian researchers identify a new disease 2Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: